NEW YORK (GenomeWeb News) — Kinaxo Biotechnologies has received around €1 million (approximately $1.4 million) from the German Ministry for Education and Research to develop a “universally applicable” chemical proteomics tool, the company said Monday.
 
The company said it plans to use the platform to “quantify small molecule-protein interactions in mammalian tissues and cell lines.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.